...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Trading questions

koo wrote -"Zenith may have a better chance of success, in my opinion."

Agreed, there may be some low hanging fruit that could be picked in the next rew years at which point all hell will break lose.

However, I don't think real value will be realized until Don retires or is replaced by a person that is both honest and competent.

I'll have my account set up this week and will start gradual accumlation of ZHCFL.

GLTA

Toinv

Share
New Message
Please login to post a reply